Cytotoxic plants from the Indian subcontinent: promising reservoir of anticancer agents
Open Access
- 20 August 2026
- journal article
- Published by Termedia Sp. z.o.o. in BioTechnologia
Abstract
In recent decades, cancer has remained the leading cause of mortality globally. The increasing incidence of cancer and the rise in the mortality rate pose substantial challenges for effective management strategies. Currently, several chemotherapeutic agents, including cisplatin, doxorubicin, and gemcitabine, are routinely used as frontline treatment options for cancer. Although these agents exhibit initial efficacy during the early stages of tumor development, their widespread application in clinical settings is significantly limited by their lack of selectivity, high cost, and toxicity to normal tissues. Phytochemicals have been recognized as promising alternatives to address these limitations. Their remarkable anticancer efficacy is attributed to various distinct mechanisms. Additionally, they are cost-effective and relatively nontoxic, which represent a significant advantage over conventional treatment approaches. To date, only a few phytochemicals, including resveratrol, gingerol, curcumin, and epigallocatechin-3-gallate, have progressed to clinical application. However, the current array of these phytochemicals is inadequate to meet the increasing demand for novel medicines against cancer. Thus, ethnopharmacology has emerged as a promising avenue for discovering and developing novel anticancer drugs. Medicinal plants from the Indian subcontinent are a valuable resource of diverse phytochemicals, which have traditionally been used for treating several health conditions and diseases. However, the evaluation of potential of these phytochemicals as anticancer medicines has largely been limited to preliminary screening. Therefore, this review specifically explores potent anticancer plants native to the Indian subcontinent that are yet to undergo rigorous clinical validation. It includes 60 plants from 44 families and details their therapeutic targets in various malignant cancers. It also discusses the major challenges and potential prospects for their effective application in cancer treatment.Keywords
This publication has 142 references indexed in Scilit:
- Introduction: Ethnomedicine and Tribal Healing Practices in India: Challenges and Possibilities of Recognition and Integration2023
- Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic predictionMolecular Diversity, 2022
- Exposures to pesticides and risk of cancer: Evaluation of recent epidemiological evidence in humans and paths forwardInternational Journal of Cancer, 2022
- Tomentosin inhibits cell proliferation and induces apoptosis in MOLT‐4 leukemia cancer cells through the inhibition of mTOR/PI3K/Akt signaling pathwayJournal of Biochemical and Molecular Toxicology, 2021
- Heterologous overexpression of Nothapodytes foetida strictosidine synthase enhances levels of anti-cancer compound camptothecin in Ophiorrhiza rugosaPlant Cell, Tissue and Organ Culture (PCTOC), 2020
- Role of Ayurveda in Cancer Treatment2019
- Intricatinol synergistically enhances the anticancerous activity of cisplatin in human A549 cells via p38 MAPK/p53 signallingApoptosis, 2017
- Cytotoxic and Melanogenesis‐Inhibitory Activities of Limonoids from the Leaves of Azadirachta indica (Neem)Chemistry & Biodiversity, 2014
- Limonoids and Flavonoids from the Flowers of Azadirachta indica var. siamensis, and Their Melanogenesis‐Inhibitory and Cytotoxic ActivitiesChemistry & Biodiversity, 2014
- Anti‐inflammatory Activities of Eleven Centaurea Species Occurring in the Carpathian BasinPhytotherapy Research, 2012